Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

PloS One
Richard Y ZhaoBernard L Mirkin

Abstract

Several unique biological features of HIV-1 Vpr make it a potentially powerful agent for anti-cancer therapy. First, Vpr inhibits cell proliferation by induction of cell cycle G2 arrest. Second, it induces apoptosis through multiple mechanisms, which could be significant as it may be able to overcome apoptotic resistance exhibited by many cancerous cells, and, finally, Vpr selectively kills fast growing cells in a p53-independent manner. To demonstrate the potential utility of Vpr as an anti-cancer agent, we carried out proof-of-concept studies in vitro and in vivo. Results of our preliminary studies demonstrated that Vpr induces cell cycle G2 arrest and apoptosis in a variety of cancer types. Moreover, the same Vpr effects could also be detected in some cancer cells that are resistant to anti-cancer drugs such as doxorubicin (DOX). To further illustrate the potential value of Vpr in tumor growth inhibition, we adopted a DOX-resistant neuroblastoma model by injecting SK-N-SH cells into C57BL/6N and C57BL/6J-scid/scid mice. We hypothesized that Vpr is able to block cell proliferation and induce apoptosis regardless of the drug resistance status of the tumors. Indeed, production of Vpr via adenoviral delivery to neuroblastoma cel...Continue Reading

References

Dec 1, 1975·The Keio Journal of Medicine·Y UeyamaT Nomura
Feb 3, 1986·European Journal of Biochemistry·G MatlashewskiL Crawford
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·E Bogenmann
Feb 1, 1997·DNA and Cell Biology·S MahalingamD B Weiner
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·S M ZemanD M Crothers
Nov 24, 1999·European Journal of Biochemistry·K Wecker, B P Roques
Nov 24, 2001·Vision Research·S N Yang, G W McConkie
Jan 5, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·L LothsteinT W Sweatman
Jan 30, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Robert T ElderYuqi Zhao
Jul 11, 2002·American Journal of Physiology. Cell Physiology·Paul J SmithRachel J Errington
Mar 5, 2003·Journal of Molecular Biology·N MorelletB P Roques
Jan 9, 2004·Cancer Nursing·Judy Wollin, Ruth Elder
Sep 29, 2004·Journal of Virology·Zsigmond BenkoRichard Yuqi Zhao
Mar 30, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Feng QianShengli Yang
Oct 28, 2005·Current Gene Therapy·Eeva K Broberg, Veijo Hukkanen
Nov 25, 2005·Current Drug Delivery·Karuppiah MuthumaniDavid B Weiner
Dec 8, 2005·Indian Journal of Ophthalmology·Pratima KathilLingam Gopal
Mar 8, 2006·Apoptosis : an International Journal on Programmed Cell Death·S ZelivianskiR Y Zhao
Mar 21, 2006·Journal of Cellular Physiology·Natalie O KarpinichJohn L Farber
Aug 26, 2006·Biochemical and Biophysical Research Communications·Katsuo Suzuki, Kazuhide Takahashi
Sep 5, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Andrea N McCrayRichard Heller
Jan 11, 2007·The Journal of Biological Chemistry·Ge LiRichard Y Zhao
May 5, 2007·Journal of Cellular Biochemistry·Elena A OstrakhovitchM George Cherian
Jul 12, 2007·Molecular Medicine·Dong LiangRichard Y Zhao
Aug 19, 2007·The Journal of Pharmacology and Experimental Therapeutics·Polly A HofmannLeonard Lothstein

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
flow cytometry
xenograft
protein assay
electrophoresis

Software Mentioned

ModFit
Mock

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.